• RSL3: A Glutathione Peroxidase 4 Inhibitor Empowering Ferrop

  2026-06-29

  RSL3, a benchmark glutathione peroxidase 4 inhibitor, unlocks precise ferroptosis induction and synthetic lethality in RAS-driven cancer models. This guide delivers actionable protocols, troubleshooting wisdom, and interpretation strategies grounded in the latest lipid peroxidation and membrane biology advances.

• Birinapant (TL32711): Applied Protocols for Cancer Apoptosis

  2026-06-28

  Birinapant (TL32711) delivers high-fidelity apoptosis induction through targeted IAP antagonism, enabling precise modulation of cell death in cancer models. This article details experimental workflows, troubleshooting strategies, and translational guidance for maximizing data quality in chemoradiotherapy sensitivity studies.

• Z-VAD-FMK: Pan-Caspase Inhibitor for Apoptosis Pathway Analy

  2026-06-27

  Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor widely used as a tool in apoptosis pathway research. Its mechanism prevents the activation of caspase-3 and related proteases, making it indispensable for dissecting apoptotic versus non-apoptotic cell death in cancer and immunology models. APExBIO’s A1902 formulation offers high solubility and validated performance for in vitro and in vivo applications.

• Prednisolone: Synthetic Glucocorticoid for Inflammation Modu

  2026-06-26

  Prednisolone, a synthetic glucocorticoid, is a high-purity research tool for investigating glucocorticoid receptor signaling and inflammation modulation. Its well-characterized solubility and storage parameters ensure reproducibility in immunology research. Recent studies highlight its integration into advanced degradation workflows targeting transmembrane proteins.

• TSPAN18 Stabilizes STIM1 to Drive Prostate Cancer Bone Metas

  2026-06-26

  Zhou et al. uncover a novel pathway driving bone metastasis in prostate cancer, showing that TSPAN18 stabilizes STIM1 by blocking its ubiquitination by TRIM32. This mechanism enhances calcium signaling and metastatic progression, offering new targets for hormone-responsive cancer research.

• Iptacopan (LNP023): Applied Workflows for Complement Inhibit

  2026-06-25

  Iptacopan (LNP023) enables precise, reversible inhibition of the alternative complement pathway, unlocking robust experimental control in both cellular assays and animal models. This article guides researchers through optimized workflows, comparative advantages, and practical troubleshooting strategies, grounded in clinical and preclinical evidence.

• Lipid Scrambling Suppresses Ferroptosis and Promotes Tumor I

  2026-06-25

  Yang et al. (2025) demonstrate that TMEM16F-mediated lipid scrambling at the plasma membrane critically inhibits ferroptosis by redistributing phospholipids and reducing membrane tension. Their findings reveal a new mechanistic link between membrane lipid dynamics and tumor immune rejection, highlighting a potential therapeutic target for enhancing cancer immunotherapy.

• Apicidin as a Histone Deacetylase Inhibitor: Applied Workflo

  2026-06-24

  Apicidin unlocks precise epigenetic modulation, making it invaluable for cancer biology and reproductive toxicology. Discover how to optimize experimental workflows, troubleshoot solubility, and leverage the latest reference findings for robust, reproducible outcomes.

• Antimycin A4: Unveiling Mechanistic Precision in Metabolic A

  2026-06-23

  Explore how Antimycin A4, a potent ATP-citrate lyase inhibitor, advances metabolic research through precise dual-pathway inhibition. This article uniquely dissects mechanistic selectivity, structural considerations, and best practices for mitochondrial and lipid biosynthesis studies.

• Differential Mechanisms of Chuanxiong Cortex and Pith in CHD

  2026-06-23

  This study applies SPME-GC×GC-MS and network pharmacology to reveal the distinct bioactive profiles and mechanistic pathways of rhizome cortex and pith from Ligusticum chuanxiong in coronary heart disease (CHD) prevention. Findings highlight significant spatial and chemical heterogeneity, supporting precision use of herbal components for cardiovascular intervention.

• Cisplatin (CDDP): Optimizing Apoptosis Assays and Tumor Inhi

  2026-06-22

  Cisplatin (CDDP) stands as a gold-standard agent for apoptosis and tumor growth inhibition studies, underpinned by robust mechanistic evidence and validated workflows. This article delivers actionable protocol enhancements, troubleshooting strategies, and a translation of recent breakthroughs for maximizing Cisplatin's impact in cancer research.

• Pregnenolone Carbonitrile in Hepatic Research: Protocols & I

  2026-06-22

  Pregnenolone Carbonitrile (PCN) stands out as the benchmark PXR agonist for dissecting hepatic detoxification and antifibrotic pathways, now proven to mediate gut-liver axis cross-talk in sepsis models. This guide delivers actionable workflows, troubleshooting insights, and novel applications enabled by PCN’s mechanistic versatility.

• Halazone: Applied Protocols for Antimicrobial and Neurophysi

  2026-06-21

  Halazone stands at the intersection of water disinfection and neurophysiology, offering robust antimicrobial action and unique sodium channel modulation. This guide presents evidence-based workflows, troubleshooting insights, and advanced applications that unlock new value from this versatile antimicrobial sulfonamide derivative.

• Birinapant (TL32711): Redefining Apoptosis for Translational

  2026-06-20

  Explore how Birinapant (TL32711) empowers translational researchers to overcome resistance in cancer models by targeting IAP-mediated apoptosis. This article weaves mechanistic insight, protocol guidance, and benchmarking against biomarker-driven strategies, such as MDM1-mediated p53 regulation, to provide practical, evidence-backed strategies for advancing apoptosis research and therapeutic innovation.

• Caspofungin for Candida Research: Mechanistic Precision & Ev

  2026-06-19

  Explore Caspofungin, a potent lipopeptide antifungal drug, through a mechanistic and application-focused lens. This article uniquely connects β-(1,3)-D-glucan biosynthesis inhibition to practical assay design, offering strategic insights distinct from standard protocol guides.

11656 records 6/778 page Previous Next First page 上5页 678910 下5页 Last page